Agoracom Blog Home

Archive for the ‘Bougainville Ventures’ Category

PRIMO Nutraceuticals Inc. $PRMO.ca – Top 5 Benefits of #CBD Oil $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:23 AM on Monday, November 11th, 2019

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

Top 5 Benefits of CBD Oil

  • Did you know that there are more than 100 chemical elements present in the cannabis plant, with CDB oil being only one of them?
  • This oil has not only proven to be an effective treatment for insomnia, stress and other medical conditions, it also helps improve mental health.

By Guest Contributor

CBD has been found to be an effective treatment option for multiple physical and psychological conditions. But, before you start, here are a few benefits you should know.

Did you know that there are more than 100 chemical elements present in the cannabis plant, with CDB oil being only one of them? This oil has not only proven to be an effective treatment for insomnia, stress and other medical conditions, it also helps improve mental health.

The best part is that although found in the cannabis plant, it does have any intoxicating properties and is safe for use by anyone.

However, it is important to buy CBD oil, glass bong bowls and other devices only from the best online smoke shop, says BomDiggidy, a leading provider of a wide range of CBD infused products, including body butter, lip balm, soap and roll-ons.

1.      Reduces Anxiety and Depression

According to the Anxiety and Depression Association of America, 6% of Americans are affected by depression and 18% by anxiety. CBD oil has proven to be one of the best cures for these mental health issues. Serotonin is a natural mood enhancer, released in the brain, and the usage of the oil can help regulate and stabilize this process.

A study published in the Journal of Psychopharmacology revealed that an oral dose of 400mg could help alleviate depression and social anxiety. It also helps the brain minimize and control the breakdown of Anandamide, the “bliss” element. This, in turn, improves the mental state to a great extent.

2.      CBD and  Cancer

Research shows that non-psychoactive CBD oils have anti-cancer properties. In fact, it can even help kill cancer cells in humans and prevent them from spreading across the body. Apart from this, many side effects of chemotherapy and other cancer treatments, such as nausea, pain, vomiting and so on are relieved or prevented.

3.      Helps Improve Sleep

CBD improves the quality of sleep for people with arthritis and Parkinson’s disease. Since it is a good cure for a number of other discomforts, such as pain, stress, anxiety and so on, it automatically induces sleep by taking care of the discomfort.

4.      Cures Skin Conditions

CBD has been also proven to improve skin conditions like acne, by fighting inflammation. It is widely being used in creams and lotions to help clear breakouts by reducing sebum production. CBD oil also has antioxidant properties, which fight wrinkles, dullness and other signs of aging skin. It also works great for people with sensitive skin because of its soothing properties, which minimize redness and other types of irritation.

5.      Helps Ease Chronic Pain

When taken in a moderate amount, under the tongue, CBD oils can help in curing chronic pain and inflammation in the human body, including multiple sclerosis and arthritis. This is done by influencing the endocannabinoid receptor activity and affecting the neurotransmitters. It also minimizes surgical and nerve pain.

Source: https://southfloridareporter.com/top-5-benefits-of-cbd-oil/

PRIMO Nutraceuticals Inc. $PRMO.ca – Ask Our Experts: What’s The Big Deal About #CBD? $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 5:54 PM on Monday, November 4th, 2019

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

Ask Our Experts: What’s The Big Deal About CBD?

  • CBD is used by all types of consumers, purchasing CBD-infused products for a variety of reasons
  • A recent Gallup survey found that one in seven Americans report using CBD for a range of medical and therapeutic purposes

By New Frontier Data

Q: There is a lot of media coverage about CBD, and it seems to be appearing all over the place. Who is buying all the CBD products?

A: CBD stands for cannabidiol, the second-most popular among active ingredients of the cannabis sativa plant. Cannabis contains hundreds of cannabinoids, each of which presents unique qualities and potential benefits.

CBD is used by all types of consumers, purchasing CBD-infused products for a variety of reasons. A recent Gallup survey found that one in seven Americans report using CBD for a range of medical and therapeutic purposes.

With passage of the 2018 U.S. Farm Bill which federally legalized hemp for the first time since World War II, the market for hemp-derived CBD products has seen explosive growth. Mass-marketed, hemp-derived CBD products have found their way onto retail shelves everywhere from grocery stores, coffee shops, and cosmetics retailers to veterinarians’ offices and nutritional supplement shops nationwide.

That said, there remains confusion regarding to what extent CBD is legal. The DEA has asserted that only GW Pharmaceutical’s patented Epidiolex is legally permitted to incorporate CBD oil in products. Yet attorney Garrett Graff of Hoban Law Group, who specializes in cannabis law and is part of a group who brought an appeal against the DEA ruling, has challenged that.

“It’s our understanding that cannabinoids derived from industrial hemp so long as below the 0.3 percent THC threshold are, in fact, lawful pursuant to the farm bill under federal law,” Graff posited. Since the FDA has not approved any CBD products at all, “at this point, we simply agree to disagree, and those products remain on the marketplace,” he explained.

New Frontier Data is engaged in several ongoing CBD research projects examining the marketplace in the United States and globally, and expects to release several reports about CBD consumer behaviors, patterns of use, and engagement with the market. Among the first slated for release as part of New Frontier Data’s upcoming Cannabis Consumer Insight Series of white papers is Marijuana Consumers’ CBD Use, examining the preferences and behaviors of consumers already familiar with cannabis and cannabis-derived products.

Findings from the research indicate that nearly a third (30%) of cannabis consumers are using CBD products, or nearly twice the previously reported rate among the general population. Such consumers also tend to be women (57%), especially under the age of 35 (43%), consistent with much of the current marketing of CBD products as health and wellness brand targeted specifically to women consumers.

Other key insights from the report found that:

Cannabis consumers who purchase CBD-only products are high-retention customers: Among cannabis consumers who purchased a CBD product, the overwhelming majority (85%) indicated that they were likely to make additional CBD purchases within the next six months. The current market is at an inflection point for CBD brands, as consumers are enthusiastically purchasing and trying these products, but most likely have weak brand loyalty. Identifying core consumers and developing a unique brand identity in the CBD space is am imperative for success in the near term.

Understanding the specific cannabis consumers who are most interested in CBD will be key to capturing the most lucrative consumer segment: New Frontier Data has identified nine fundamental “Cannabis Consumer Archetypes“. Among those categorized cannabis consumers, it is the Modern Lifestylers, Medical Purists, and Functional Dependents who are most likely to have purchased a CBD product. However, as access to CBD products increases, it is expected that a broader base of consumers will integrate CBD into both their daily lives and as a complement to current cannabis use.

Source: https://www.benzinga.com/markets/cannabis/19/11/14717727/ask-our-experts-whats-the-big-deal-about-cbd

PRIMO Nutraceuticals Inc. $PROM.ca Harvests 13,000 lbs of Dried Bio-mass from Oregon Hemp Farm $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 8:24 AM on Wednesday, October 30th, 2019
  • Company has completed a harvest totaling 13,000 lbs of dried bio-mass of hemp from the Oregon hemp farm.
  • The dried bio-mass hemp is currently being stored at a local drying facility located near Eugene, Oregon.
  • The value for the crop in its current state is estimated to be worth $200,000 – $300,000 USD.

VANCOUVER, British Columbia, Oct. 30, 2019 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”)is pleased to announce that further to the Company news release dated October 1, 2019 the Company has completed a harvest totaling 13,000 lbs of dried bio-mass of hemp from the Oregon hemp farm. The dried bio-mass hemp is currently being stored at a local drying facility located near Eugene, Oregon. The value for the crop in its current state is estimated to be worth $200,000 – $300,000 USD. This will be added to the 28 kilo grams of crude oil currently in inventor from last year’s harvest. 

The completion of the 2019 harvest season is a major milestone for the company and for the hemp farm in Oregon, as this is the first year hemp has been federally legal since the Farm Bill was passed. This year in Oregon alone there are nearly 63,000 acres registered growing hemp compared to the 11,500 acres growing hemp registered in 2018. This is a significant increase in the amount of hemp being grown, which solidifies the Primo strategy of providing drying facilities to the ever growing hemp market in Oregon. Primo plans to have its first drying facility built and in operation by the end of the first quarter of next year.

President, Andy Jagpal Comments:

“I am very proud and excited with the amount of dried hemp that was harvested as it surpassed our expectations by a few thousand pounds. During a time in the cannabis market where companies have spent tens of millions of dollars building out facilities and cultivation infrastructure and have little to show for it, we have two harvests under our belt and product in inventory ready for sale. Together with this year’s harvest and last year’s inventory we estimate our inventory alone to be worth between $400,000 and $500,000 USD.”

VP Sales & Distribution, Andy Dhaliwal Comments:

“The on-hand inventory and quality of the hemp as starting material is a major advantage in the current marketplace. While the revenue opportunities from the harvest are extremely promising, the hemp processing infrastructure supports the expansion of our in-house product lines, and increases our white-label offering to the USA market as well. Both of which are tremendous assets for the company.”

About Primo Nutraceuticals, Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo provides fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. In addition to the Company’s flagship hemp project in Oregon State and the Greenhouse campus in Washington State, Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors
PRIMO NUTRACEUTICALS INC.

Andy Jagpal, President and Director

To learn more about what this news means to the shareholders visit https://marketnewsfirst.com/primo-nutraceuticals, as well as on the company’s site.

For further information, please contact Zoltan, IR Representative at: 604-722-0305 [email protected]. Or toll free at 1-877-517-7816.

http://primoceuticals.com/
https://twitter.com/prmonutra
www.thriveCBD.org

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ddc63988-72ec-4630-a25d-5d418ba2ea1b

Bougainville Ventures $BOG.ca – US retail sales of #CBD to increase 133% in 2019, surpass $10 billion by 2024 $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 5:41 PM on Thursday, October 17th, 2019

SPONSOR:  Bougainville Ventures Inc (CSE: BOG) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

—————

US retail sales of CBD to increase 133% in 2019, surpass $10 billion by 2024

  • Retail sales of CBD in the U.S. are expected to surpass $1 billion in 2019 – a 133% increase over 2018 sales

DENVER, Oct. 17, 2019 — Retail sales of CBD in the U.S. are expected to surpass $1 billion in 2019 – a 133% increase over 2018 sales – and may eclipse $10 billion by 2024, according to projections from the newly released 2019 Hemp & CBD Industry Factbook, produced by the editors of Hemp Industry Daily.

The 2019 Hemp & CBD Industry Factbook predicts that retail sales of CBD in the U.S. are expected to surpass $1 billion in 2019 – a 133% increase over 2018 sales – and may eclipse $10 billion by 2024.

“The recent surge of consumer demand for CBD, coupled with increasingly easy access to CBD products, is expected to drive retail sales to about $1.1 billion-$1.3 billion in 2019,” said Kristen Nichols, editor of the 2nd Annual Hemp & CBD Industry Factbook. “We project retail CBD sales will increase to $10.3 billion by 2024, a five-year compound annual growth rate of 54%.”

When no federal agency tracks hemp as a commodity, the exclusively business focused 2019 Annual Hemp & CBD Industry Factbook provides understanding of the current and future challenges needed to make the most accurate and informed business decisions. Research-driven insights, will help business professionals understand economic, agricultural and regulatory developments impacting their positions and growth in the industry.

The 2019 Annual Hemp & CBD Industry Factbook offers:

  • 30+ charts exploring and analyzing the hemp & CBD market from critical angles including retail forecasts, consumer demand, production and more.
  • Top 10 hemp-producing state profiles exploring market conditions and retail trends.
  • Regulatory outlook, best practices, and future considerations for cultivators and processors looking to meet consumer demand
  • Benchmarks and wholesale prices, plus prices for hemp seeds and clone varietals
  • Pain points for growers and processors with a focus on input costs and per acre profits

“Imagine running a race with brand-new shoes and a burst of energy but no idea what the course looks like. That’s somewhat the position in which today’s hemp industry finds itself,” said Nichols. “Relying on deeply researched data points along the way could make the difference between hitting the finish line and running off course.”

Source: https://www.prnewswire.com/news-releases/us-retail-sales-of-cbd-to-increase-133-in-2019-surpass-10-billion-by-2024-300940056.html

Bougainville Ventures $BOG.ca – CBD Demand Soars With a Growing Number of Uses $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 1:27 PM on Tuesday, October 15th, 2019

SPONSOR:  Bougainville Ventures Inc (CSE: BOG) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

CBD Demand Soars With a Growing Number of Uses

  • Global cannabidiol market is expected to grow from USD 1.04 Billion in 2018 to USD 16.32 Billion by 2026 while registering a CAGR of 27.7% during the forecast period, according to data compiled by Reports and Data

NEW YORK, Oct. 15, 2019 – As the medical industry continues to evolve, researchers are actively looking for innovative remedies and treatments for patients. Notably, cannabis has become the topic of discussion after numerous researchers and institutions highlighted its therapeutic benefits. However, despite medical advancements throughout the cannabis industry, most federal regulators around the world have not yet moved to fully legalize cannabis for medical applications because of the psychotropic effects associated with it. Nevertheless, several regulators have decided to legalize cannabidiol, or CBD, a compound found within cannabis. CBD is a derivative found within the cannabis plant, however, unlike its tetrahydrocannabinol, or THC, counterpart, it does not induce psychoactive effects. Consequently, regulators became more inclined to legalize CBD. Primarily, the CBD industry is being accelerated by the healthcare segment.

Specifically, countries such as Australia, Canada, France, Germany, Italy, the U.K. and the U.S. have all adopted CBD-related legislation. Overall, the therapeutic grade segment dominates that overall CBD market because of increasing demand from innumerable applications. The segment accounted for 58.6% of the overall CBD market share and is expected to continue its dominance. In particular, the healthcare segment is expected to account for a total of USD 10.28 Billion of the CBD market by 2026. Moreover, the food and beverage industry is also expected to witness exponential growth. And while the U.S. and Canada are the primary drivers for the global CBD market, other international markets are also expected to greatly contribute. For instance, the Asia Pacific market is anticipated to reach USD 3.1 Billion by 2026 and exhibit a CAGR of 29.5%, while the European market is projected to grow at a CAGR of 28.9%. As a result, the global cannabidiol market is expected to grow from USD 1.04 Billion in 2018 to USD 16.32 Billion by 2026 while registering a CAGR of 27.7% during the forecast period, according to data compiled by Reports and Data.

The pharmaceutical segment of the CBD industry is expected to witness significant R&D investments to accelerate deployment and meet the medical needs of a number of diseases. Specifically, researchers have uncovered that CBD can treat a variety of diseases such as chronic pain, anxiety, depression, and cancer. And while most of these conditions would likely require a prescription from a medical practitioner, there are over-the-counter or OTC products that consumers can easily purchase at their local convenience stores in the U.S. or Canada. Consumers can purchase CBD-based products such as tinctures, topicals, patches, capsules, foods, and beverages. Typically, most OTC products are marketed as health and wellness products that are aimed to relieve minor ailments. For instance, many health and wellness retailers promote CBD as a way to stimulate relaxation or relieve small headaches. Notably, major pharmaceutical retailers such as CVS or Walgreens have also decided to add CBD products to their shelves. The two corporations added CBD products in order to provide consumers with cheaper and alternative care products. “It really does help normalize this. If Grandma can go to the store and get it, now the conversation about cannabis is going to be very different,” said Michele Ross, PhD, MBA, Research Director at Decriminalize California. “CBD business is already huge. But normalizing the culture around taking these products is going to open the door for more people to feel comfortable investing in these types of businesses. It opens up the possibility for them to be sold in more stores.”

Source: https://www.prnewswire.co.uk/news-releases/cbd-demand-soars-with-a-growing-number-of-uses-815946592.html

Bougainville Ventures Inc. Appoints Mr. Andy Dhaliwal, President of Thrive Nutrition to Vice President of Sales and Distribution $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 7:54 AM on Tuesday, October 8th, 2019
  • Company has appointed Mr. Andy Dhaliwal, President of Thrive Wellness to Vice President of Sales and Distribution for Bougainville Ventures Inc. 

VANCOUVER, British Columbia, Oct. 08, 2019 — BOUGAINVILLE VENTURES INC. (CSE: BOG) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Bougainville” or the “Company”) is pleased to announce that further to the signing of the definitive agreement to complete the acquisition of Thrive Nutrition Products Ltd. (“Thrive Wellness”) announced in the Company news release dated September 24, 2019, the Company has appointed Mr. Andy Dhaliwal, President of Thrive Wellness to Vice President of Sales and Distribution for Bougainville Ventures Inc.  Thrive Wellness is a preeminent distributor of hemp & cannabinoid-focused natural health products under the “THRIVE WELLNESS” brand.

About Thrive Nutrition Products Ltd.
Thrive Wellness is a distributor of premium hemp and natural health products with operations currently in Canada and the USA. Thrive specializes in the development, marketing and distribution of cannabinoid products refined into their own natural health product brand. The company was founded in Vancouver, British Columbia and is the first of its kind with national retail distribution in Canada. Thrive has achieved $2,500,000 CDN in sales through retail distribution, its’ e-commerce website and their relationship with Nutrition House, Canada’s leading Natural Health Product franchise. Founded in 1979 the company began franchising in 1993 and now operates over 45 retail stores, located in high profile shopping centers across Canada, and in the USA. www.nutritionhouse.com

CEO, Andy Dhaliwal Comments:

“I am very excited to be a joining a team that is extremely well positioned for significant growth in the emerging cannabis & hemp markets. I look forward to helping Bougainville continue building shareholder value and to increase our international exposure through this partnership. I am particularly keen on the CBD opportunity in the U.S., where Bougainville already has resources available.”

Mr. Dhaliwal is a pioneering expert in the marketing of cannabis, hemp, and natural health products, and brings over 12 years of experience in the industry. In addition to serving as the CEO of Thrive Wellness, he was an advisor for the Province of British Columbia’s Cannabis Operations, where he advised on corporate development and sales optimization. 

To learn more about what this news means to the shareholders visit https://marketnewsfirst.com/bog-news, as well as on the company’s site.

About the CBD Market

Bank of America projects a spend of $1.3 Billion on CBD in Canada by 2022, while $1.9 Billion is being spent in the USA currently, and another $4.4 Billion in Europe this year. Demand for CBD and Hemp is increasing year over year, with Merrill Lynch predicting an $11.5 Billion American market by 2032.

About Bougainville Ventures, Inc.

Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids in both Canada and the United States. Along with our flagship Hemp project in Oregon State and the Greenhouse campus in Washington State, the Company has proprietary formulas for cannabis edibles, topical, and tinctures.

On behalf of the Board of Directors
BOUGAINVILLE VENTURES INC.

Andy Jagpal, President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305 [email protected]. Or toll free at 1-877-517-7816

http://bougainvilleinc.com/https://twitter.com/bougainvilleincwww.thriveCBD.org

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

The Top Most Compelling Reasons to Invest in the #CBD Market – SPONSOR: #Bougainville Ventures $BOG.ca $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:52 AM on Wednesday, October 2nd, 2019

SPONSOR:  Bougainville Ventures Inc (CSE: BOG) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

The Top Most Compelling Reasons to Invest in the CBD Market

  • According to Grand View Research, the global CBD market could see a compound annual growth rate of 32.6% to $9.7billion by 2025.
  • The firm also projects that the global CBD skincare segment of the market could grow at a CAGR of 33% to $1.7 billion by 2025.

The CBD boom is here, and it’s thriving especially as major retailers just on board.  Already, Neiman Marcus, Sephora, Vitamin Shoppe, Kroger, Barney’s DSW, CVS, American Eagle, and Walgreen’s are selling CBD products. Even Shopify is now offering features for U.S. retailers of hemp and CBD, expanding its North American reach. On top of that, support for cannabis legalization is exploding. For example, a Gallup survey found that 66% of Americans are in favor of legalization. That’s up from just 60% in 2016. In addition, according to Grand View Research, the global CBD market could see a compound annual growth rate of 32.6% to $9.7billion by 2025. The firm also projects that the global CBD skincare segment of the market could grow at a CAGR of 33% to $1.7 billion by 2025.

Read More: https://www.baystreet.ca/stockstowatch/6528/The-Top-Most-Compelling-Reasons-to-Invest-in-the-CBD-Market

#CBD Use Continues to Grow as Regulators Change Tact , bodes well for #Bougainville Ventures $BOG.ca $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 11:17 AM on Tuesday, October 1st, 2019

SPONSOR:  Bougainville Ventures Inc (CSE: BOG) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

CBD Use Continues to Grow as Regulators Change Tact , bodes well for Bougainville Ventures

  • According to data compiled by Grand View Research, the global cannabidiol market is expected to reach USD 9.69 Billion by 2025 while registering a CAGR of 32.6% during the forecast period.

NEW YORK, Oct. 1, 2019 — Hemp has been used for centuries for its multi-facet applications. Previously, hemp was primarily used for industrial applications such as manufacturing textiles, fabrics, and linen. The industrial segment was the largest driver for the overall hemp market, however, following legislative efforts, the hemp-derived CBD market has emerged as the primary driver. Hemp was also commonly used as a medicinal treatment for convulsions, rheumatism, dysentery, and insomnia. However, health officials around the world had deemed hemp unsafe for consumers because it was derived from the cannabis plant.

As a result, the entire cannabis plant was listed as a Schedule 1 substance solely because of its marijuana component. The marijuana plant is packed with tetrahydrocannabinol (THC), while the hemp plant is typically cannabidiol (CBD) dominant. Although the two plants fall under the cannabis family, they are widely different in their genetic makeup and effects.

THC is the compound that is commonly known to cause psychoactive effects on the consumer, while CBD is generally known to have relaxing and soothing effects. However, despite the genetic differences, both THC and CBD are known to alleviate certain medical conditions. Researchers have even highlighted that both THC and CBD can effectively treat symptoms associated with cancer, chronic pain, epilepsy, Alzheimer’s, and Parkinson’s. However, because THC causes mind-altering effects, health officials are more inclined to accept CBD as a medicinal treatment than THC. As a result, countries such as Canada, Germany, South Korea, the U.K., and the U.S. have legalized CBD for medical purposes. According to data compiled by Grand View Research, the global cannabidiol market is expected to reach USD 9.69 Billion by 2025 while registering a CAGR of 32.6% during the forecast period.

Read More: https://www.prnewswire.co.uk/news-releases/cbd-use-continues-to-grow-as-regulators-change-tact-829476982.html

Bougainville Ventures $BOG.ca Oregon Hemp Farm Begins Harvesting $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 6:50 AM on Tuesday, October 1st, 2019
  • hemp farm in Oregon has a crew of 20 people harvesting 28,000 plants and will be completed over the next couple of weeks
  • Worm Casting team has arranged for drying of the bio-mass with a local drying facility close by while our 15,000 Sq ft., drying facility is being built.
  • Once processed, it will be sold along with the 28 kg of distillate CBD oil that was processed by Dab Extraction Associates a mobile extraction company earlier this year.

Vancouver, British Columbia–(October 1, 2019) – BOUGAINVILLE VENTURES INC. (CSE: BOG) (OTC Pink: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Bougainville” or the “Company”) is pleased to announce that harvesting on the Oregon Hemp farms has begun. The hemp farm in Oregon has a crew of 20 people harvesting 28,000 plants and will be completed over the next couple of weeks.

The Worm Casting team has arranged for drying of the bio-mass with a local drying facility close by while our 15,000 Sq ft., drying facility is being built. Once processed, it will be sold along with the 28 kg of distillate CBD oil that was processed by Dab Extraction Associates a mobile extraction company earlier this year.



Harvest Begins

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6334/48347_5298ce62f42f2863_001full.jpg

Andy Jagpal, President Comments:

“The hemp Industry in Oregon is booming and so is the demand for CBD. According to an Oregon based Hemp publication there were little over 580 growers, and 11,500 acres growing Hemp registered in 2018. This year, there are 1,900 growers, and nearly 63,000 acres registered growing hemp. The Hemp market is bigger than the medical marijuana and recreational marijuana put together, and as the Baby Boomers are just now discovering the benefits of CBD the demand for Hemp has an aggressive growth curve that is just beginning.”

To learn more about what this news means to the shareholders visit https://marketnewsfirst.com/bog-news

About the Hemp Market

In 2018, the legal cannabis market was valued at $11.9 billion in the United States and is expected to be worth $66.3 billion by the end of 2025, which is a compounded annual growth rate of nearly 24 percent, according to Market Research.

About Bougainville Ventures, Inc.

Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids in both Canada and the United States. Along with our flagship Hemp project in Oregon State and the Greenhouse campus in Washington state, the Company has proprietary formulas for cannabis edibles, topical, and tinctures.

On behalf of the Board of Directors
BOUGAINVILLE VENTURES INC.

Andy Jagpal, President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305 [email protected]. Or toll free at 1-877-517-7816

http://bougainvilleinc.com/
https://twitter.com/bougainvilleinc

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/48347

Bougainville Ventures $BOG.ca – #Cannabis Execs Cheer Congress’ Approval of #Pot Business Banking $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 2:53 PM on Friday, September 27th, 2019

SPONSOR:  Bougainville Ventures Inc (CSE: BOG) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

Cannabis Execs Cheer Congress’ Approval of Pot Business Banking

  • In the crush of impeachment news, few noticed a major development in the legal cannabis industry this week.
  • The Secure and Fair Enforcement (SAFE) Banking Act, which allows banks to offer financial services to cannabis companies that are operating legally within their own state, passed in the House of Representatives by a decisive margin of 322 – 103 and is moving on to the Senate.

Julie Weed Contributor

In the crush of impeachment news, few noticed a major development in the legal cannabis industry this week. The Secure and Fair Enforcement (SAFE) Banking Act, which allows banks to offer financial services to cannabis companies that are operating legally within their own state, passed in the House of Representatives by a decisive margin of 322 – 103 and is moving on to the Senate.

There is some flavor of legal cannabis market in more than 30 states, but the plant’s federal categorization as a Schedule One drug, has meant that banks would not offer services to companies growing, processing or selling marijuana. Without access to checks and credit cards, business operators have had to deal in large amounts of cash, making them targets for robbery and complicating the tax-paying procedures.

It’s important for legal marijuana businesses to access banking basics, like making deposits, transferring funds and taking out loans said Steve DeAngelo, co-founder of the cannabis dispensary chain in California, Harborside. Those financial activities, “foster economic growth and the creation of jobs that enhance the community,” he said.  

And, it’s only fair according to DeAngelo. “The cannabis industry currently pays the federal government over $5 billion in taxes each year,” he said, “and it deserves to get the benefits all other business have access to, namely safe banking.”

The law will help keep investment in the United States and aid company growth said Adrian Sedlin, chief executive of Canndescent, a cannabis company. Access to banking would mean US cannabis companies could “stop turning to the Canadian capital markets, paying usurious rates for financing, and dealing with burdensome amounts of paper currency,” said Sedlin. 

Michael Goldberg, a partner at Altitude Investment Management urges the Senate to vote in support of this measure in the coming months. ”The regulated cannabis market has consistently lacked adequate financial infrastructures and resources that are afforded to mainstream businesses due to federal regulations,” he said. 

Doug Gordon, executive vice president and head of LeafLink Financial said he looks forward to “the advancement of this legislation through the Senate to empower the growth and development of the industry.” 

The legal cannabis market has been a “job machine” and now employs 250,000 Americans according to Keegan Peterson, chief executive of Würk which creates payroll and human resources software for cannabis companies. The lack of banking access “puts the incomes of these employees at risk and causes unnecessary financial challenges for business owners.”

Source: https://www.forbes.com/sites/julieweed/2019/09/27/cannabis-executives-cheer-congress-approval-of-pot-business-banking/#707e7a9c712c